Literature DB >> 7983573

Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A.

B Morrow1, H Ramsey, D R Soll.   

Abstract

It was previously demonstrated that the genes PEP1 and Op4 are selectively transcribed in the opaque phase of the white-opaque transition in Candida albicans strain WO-1, and that the gene Wh11 is selectively transcribed in the white phase. However, the white-opaque transition occurs in only a minority of C. albicans strains and the opaque cell phenotype is highly specialized. To test whether these genes are regulated in more mainstream switching systems in C. albicans, their expression was analysed in the switching system of the laboratory strain 3153A. Both PEP1 and Op4 are not expressed in the basic smooth phenotype of 3153A, but they are expressed in switch phenotypes. However, expression is dissociated. Op4 is expressed in irregular wrinkle, star and revertant-smooth cells, while PEP1 is expressed only in star cells. Wh11 is expressed in the basic smooth and three tested variant phenotypes and is again associated with growth in a round budding form. The results support the general conclusion that PEP1 and Op4 are under the strict regulation of switching in C. albicans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983573     DOI: 10.1080/02681219480000361

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  20 in total

1.  Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.

Authors:  C Kvaal; S A Lachke; T Srikantha; K Daniels; J McCoy; D R Soll
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells.

Authors:  T Srikantha; L K Tsai; K Daniels; D R Soll
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

3.  In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Authors:  J R Naglik; G Newport; T C White; L L Fernandes-Naglik; J S Greenspan; D Greenspan; S P Sweet; S J Challacombe; N Agabian
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Susceptibility of Candida species to photodynamic effects of photofrin.

Authors:  Joseph M Bliss; Chad E Bigelow; Thomas H Foster; Constantine G Haidaris
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

5.  TOS9 regulates white-opaque switching in Candida albicans.

Authors:  Thyagarajan Srikantha; Anthony R Borneman; Karla J Daniels; Claude Pujol; Wei Wu; Michael R Seringhaus; Mark Gerstein; Song Yi; Michael Snyder; David R Soll
Journal:  Eukaryot Cell       Date:  2006-09-01

6.  Control of white-opaque phenotypic switching in Candida albicans by the Efg1p morphogenetic regulator.

Authors:  A Sonneborn; B Tebarth; J F Ernst
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Characterization of switch phenotypes in Candida albicans biofilms.

Authors:  Y Jin; Y H Samaranayake; H K Yip; L P Samaranayake
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

8.  A MADS box protein consensus binding site is necessary and sufficient for activation of the opaque-phase-specific gene OP4 of Candida albicans.

Authors:  S R Lockhart; M Nguyen; T Srikantha; D R Soll
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

9.  Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity.

Authors:  Yeissa Chabrier-Roselló; Thomas H Foster; Nelissa Pérez-Nazario; Soumya Mitra; Constantine G Haidaris
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

10.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.